Header Logo

Mohit Chopra

Concepts (131)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cocaine-Related Disorders
4
2025
82
0.730
Why?
Stress Disorders, Post-Traumatic
3
2016
380
0.730
Why?
Depressive Disorder
3
2009
279
0.730
Why?
Opioid-Related Disorders
5
2025
456
0.620
Why?
Memantine
3
2014
22
0.590
Why?
Methadone
3
2025
127
0.590
Why?
Health Status
2
2016
424
0.490
Why?
Excitatory Amino Acid Antagonists
2
2013
30
0.490
Why?
Social Stigma
1
2016
64
0.490
Why?
Obsessive-Compulsive Disorder
1
2011
33
0.380
Why?
Patient Acceptance of Health Care
1
2016
450
0.370
Why?
Benzodiazepines
1
2011
94
0.370
Why?
Narcotics
2
2025
50
0.360
Why?
Disulfiram
2
2025
5
0.330
Why?
Alzheimer Disease
3
2014
679
0.330
Why?
Quality of Life
2
2016
1137
0.330
Why?
Depressive Disorder, Major
3
2011
245
0.320
Why?
Apolipoprotein E4
1
2009
44
0.320
Why?
Antipsychotic Agents
1
2011
292
0.310
Why?
Methadyl Acetate
1
2008
1
0.310
Why?
Reward
1
2009
83
0.310
Why?
Psychiatric Status Rating Scales
2
2013
379
0.310
Why?
Narcotic Antagonists
2
2014
121
0.300
Why?
Naloxone
1
2008
57
0.300
Why?
Buprenorphine
2
2014
181
0.280
Why?
Aging
1
2013
710
0.280
Why?
Cognition Disorders
1
2008
215
0.270
Why?
Alcohol Deterrents
1
2025
6
0.240
Why?
Dementia
1
2008
248
0.240
Why?
Geriatric Assessment
1
2006
159
0.240
Why?
Long-Term Care
1
2006
176
0.230
Why?
Aged
12
2016
13416
0.230
Why?
Male
19
2025
27739
0.230
Why?
Opiate Substitution Treatment
3
2025
187
0.220
Why?
Female
18
2025
30705
0.220
Why?
Depression
3
2016
828
0.210
Why?
Hallucinations
1
2003
15
0.210
Why?
Vitamin E
2
2014
52
0.210
Why?
Treatment Refusal
1
2003
54
0.210
Why?
Mental Competency
1
2003
55
0.200
Why?
Anxiety
3
2016
387
0.200
Why?
Comorbidity
3
2016
1078
0.200
Why?
Informed Consent
1
2003
138
0.190
Why?
Antioxidants
2
2014
241
0.190
Why?
Attitude to Health
1
2003
279
0.180
Why?
Humans
21
2025
59360
0.170
Why?
Nursing Homes
1
2006
661
0.170
Why?
Decision Making
1
2003
395
0.160
Why?
Double-Blind Method
6
2025
715
0.150
Why?
Severity of Illness Index
5
2014
1479
0.140
Why?
Veterans
3
2016
728
0.140
Why?
Dose-Response Relationship, Drug
3
2025
806
0.140
Why?
Cyclohexanecarboxylic Acids
1
2014
8
0.110
Why?
Dopamine Agents
1
2014
11
0.110
Why?
Amines
1
2014
29
0.110
Why?
Sertraline
1
2014
58
0.110
Why?
gamma-Aminobutyric Acid
1
2014
70
0.110
Why?
Aged, 80 and over
4
2014
5128
0.110
Why?
Adult
8
2025
15669
0.100
Why?
Alcohol-Related Disorders
1
2013
35
0.100
Why?
Alcoholism
1
2016
309
0.100
Why?
Longitudinal Studies
2
2013
1189
0.100
Why?
Motivation
1
2014
273
0.100
Why?
Disease Progression
2
2014
1122
0.090
Why?
Combat Disorders
1
2011
10
0.090
Why?
Patient Compliance
2
2014
349
0.090
Why?
Activities of Daily Living
2
2014
289
0.090
Why?
Life Change Events
1
2011
65
0.090
Why?
Internet
1
2014
448
0.090
Why?
Wounds and Injuries
1
2013
229
0.090
Why?
Amphetamine-Related Disorders
1
2009
12
0.080
Why?
Chronic Disease
1
2013
716
0.080
Why?
Methamphetamine
1
2009
22
0.080
Why?
Directive Counseling
1
2009
38
0.080
Why?
Benzhydryl Compounds
1
2009
48
0.080
Why?
Arkansas
1
2008
4
0.080
Why?
Logistic Models
2
2011
1232
0.080
Why?
Cocaine
2
2025
96
0.080
Why?
United States
3
2013
7390
0.080
Why?
Secondary Prevention
1
2009
151
0.080
Why?
Self Concept
1
2008
105
0.070
Why?
Middle Aged
6
2025
16317
0.070
Why?
Paroxetine
2
2004
15
0.070
Why?
Substance Withdrawal Syndrome
1
2008
119
0.070
Why?
Sex Characteristics
1
2008
197
0.070
Why?
Neuropsychological Tests
1
2008
371
0.070
Why?
Psychometrics
1
2008
362
0.070
Why?
Multivariate Analysis
1
2008
902
0.070
Why?
Mental Health Services
2
2011
268
0.070
Why?
Dysthymic Disorder
1
2005
8
0.060
Why?
Psychotherapy
1
2006
92
0.060
Why?
Mortality
1
2006
155
0.060
Why?
Pindolol
1
2004
2
0.060
Why?
Antidepressive Agents
1
2006
211
0.060
Why?
Prolactin
1
2004
40
0.060
Why?
Antidepressive Agents, Second-Generation
1
2004
29
0.060
Why?
Tryptophan
1
2004
54
0.060
Why?
Disability Evaluation
1
2005
199
0.060
Why?
Treatment Outcome
3
2025
5284
0.060
Why?
Combined Modality Therapy
2
2014
355
0.050
Why?
Adrenergic beta-Antagonists
1
2004
147
0.050
Why?
Cross-Sectional Studies
2
2011
2373
0.050
Why?
Hydrocortisone
1
2004
187
0.050
Why?
Commitment of Mentally Ill
1
2003
68
0.050
Why?
Drug Therapy, Combination
2
2014
452
0.050
Why?
Surveys and Questionnaires
1
2008
2513
0.040
Why?
Follow-Up Studies
1
2005
2337
0.040
Why?
Primary Health Care
1
2005
643
0.040
Why?
Adolescent
1
2009
5824
0.040
Why?
Remission Induction
2
2011
137
0.040
Why?
Diagnostic and Statistical Manual of Mental Disorders
2
2011
116
0.040
Why?
Retrospective Studies
1
2008
6071
0.030
Why?
GABA Agonists
1
2014
5
0.030
Why?
Diagnosis, Dual (Psychiatry)
1
2014
79
0.030
Why?
Cross-Over Studies
2
2004
153
0.030
Why?
Cholinesterase Inhibitors
1
2014
45
0.030
Why?
Residence Characteristics
1
2014
215
0.030
Why?
Recurrence
1
2014
603
0.020
Why?
Medication Adherence
1
2014
239
0.020
Why?
Risk Factors
2
2011
4984
0.020
Why?
Caregivers
1
2014
231
0.020
Why?
Analgesics, Opioid
1
2014
483
0.020
Why?
Self Report
1
2010
359
0.020
Why?
Alcohol Drinking
1
2010
288
0.020
Why?
Sex Factors
1
2011
935
0.020
Why?
Pilot Projects
1
2009
914
0.020
Why?
Mass Screening
1
2011
645
0.020
Why?
Fluoxetine
1
2004
44
0.010
Why?
Young Adult
1
2014
4267
0.010
Why?
Substance-Related Disorders
1
2011
682
0.010
Why?
Drug Administration Schedule
1
2004
283
0.010
Why?
Chopra's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (131)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_